Rallybio Corporation (RLYB) Misses Q2 EPS by 30c

Rallybio Corporation (NASDAQ: RLYB) reported Q2 EPS of ($0.67), $0.30 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Trump on North Korea's Kim Jong Un: he has responded to me
• China retail sales growth slows to 0.6% in July, Macquarie comments